NCT05177523
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis No drug interventions Not Available Not Available recruiting NCT06436131
The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis No drug interventions treatment Not Available completed NCT02305264
Imaging of Intracerebral Inflammation in MS diagnostic Not Available completed NCT06526364
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) No drug interventions Not Available Not Available not_yet_recruiting NCT05168384
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis No drug interventions treatment 1 / 2 recruiting NCT05357833
Novel Imaging Markers in SPMS diagnostic 0 completed NCT05663853
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients No drug interventions Not Available Not Available completed NCT00888277
Bayer/Cognitive Assessments With Multiple Sclerosis Subjects No drug interventions Not Available Not Available completed NCT01433497
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis treatment 3 completed NCT03653585
Cortical Lesions in Patients With Multiple Sclerosis No drug interventions Not Available Not Available completed NCT02308137
Domperidone in Secondary Progressive Multiple Sclerosis (SPMS) treatment 2 completed NCT01982942
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis treatment 2 completed NCT06276634
Intermittent Hypoxia in Persons With Multiple Sclerosis No drug interventions treatment Not Available recruiting NCT06516458
Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis No drug interventions Not Available Not Available recruiting NCT05013463
Hydroxychloroquine and Indapamide in SPMS treatment 2 unknown_status NCT04918225
Motor Asymmetry in Progressive Multiple Sclerosis Patients No drug interventions Not Available Not Available recruiting NCT06390930
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS No drug interventions treatment Not Available not_yet_recruiting NCT06413602
The Synergistic Effects of AIH and FES in Persons With MS No drug interventions treatment Not Available not_yet_recruiting NCT02506751
Open-label Study of Liothyronine in MS treatment 1 completed NCT04260711
Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS). treatment Not Available unknown_status NCT00468611
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis treatment 3 terminated NCT06138132
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis treatment 1 recruiting NCT02430532
BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis treatment 3 terminated NCT05122559
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis treatment 2 recruiting NCT05204459
MS-ResearchBiomarkerS No drug interventions Not Available Not Available recruiting NCT02273635
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS treatment 1 / 2 unknown_status NCT04993274
Sensitivity of Motor Assessment in MS - a Prospective Cohort Study No drug interventions Not Available Not Available unknown_status NCT05385731
MUSCLE - Nordic Walking in MUltiple SCLErosis No drug interventions treatment Not Available not_yet_recruiting NCT06384976
A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis No drug interventions treatment 2 not_yet_recruiting NCT00587691
Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis No drug interventions treatment 1 / 2 completed NCT05961644
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). treatment 2 / 3 recruiting NCT04211740
Phase II Clinical Trial of OCH-NCNP1 No drug interventions treatment 2 completed NCT02988401
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis treatment 1 / 2 completed NCT05496881
Exercise Effects in Multiple Sclerosis No drug interventions supportive_care Not Available recruiting NCT06588387
A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis No drug interventions Not Available Not Available completed NCT02549703
Mitochondrial Dysfunction and Disease Progression No drug interventions Not Available Not Available completed NCT02266121
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis No drug interventions treatment Not Available terminated NCT06526000
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies No drug interventions Not Available Not Available completed NCT06395909
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis No drug interventions Not Available Not Available completed NCT04047628
Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) treatment 3 recruiting NCT03896217
Simvastatin in Secondary Progressive Multiple Sclerosis treatment 2 completed NCT03783416
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis No drug interventions other 1 recruiting NCT03493841
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis treatment 1 completed NCT02228213
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis No drug interventions treatment 2 completed NCT02207075
Measuring Active Microglia in Progressive Multiple Sclerosis No drug interventions Not Available Not Available completed NCT01950234
ACTH in Progressive Forms of MS treatment 2 terminated NCT01910259
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial treatment 2 completed NCT01228396
AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis treatment 2 unknown_status NCT01191996
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis No drug interventions treatment 1 / 2 completed NCT00647348
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis treatment 2 completed NCT00146159
Study Evaluating Mitoxantrone in Multiple Sclerosis treatment 3 terminated NCT06360861
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis No drug interventions treatment 1 completed NCT04925557
Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis diagnostic 2 / 3 completed NCT06372145
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. treatment 3 recruiting NCT05826028
Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGo No drug interventions Not Available Not Available completed NCT05349474
Metformin Treatment in Progressive Multiple Sclerosis treatment 0 recruiting NCT04239664
Acceptance Based Telephone Support When Transitioning to SPMS No drug interventions supportive_care Not Available completed NCT04688788
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis treatment 3 active_not_recruiting NCT04634994
Novel Assessment of Synaptic Density in Progressive MS No drug interventions diagnostic 0 unknown_status NCT05029609
Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS treatment 1 withdrawn NCT06292923
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients treatment 2 recruiting NCT03315923
Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients treatment 2 / 3 completed NCT03283826
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis No drug interventions treatment 1 / 2 terminated NCT02253264
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients treatment 1 completed NCT02495766
Autologous Mesenchymal Stromal Cells for Multiple Sclerosis treatment 1 / 2 completed NCT01737372
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis No drug interventions Not Available Not Available completed NCT01684761
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis No drug interventions treatment 2 completed NCT01665144
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) treatment 3 completed NCT01647321
Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis No drug interventions treatment Not Available completed NCT01416181
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis treatment 3 terminated NCT01181089
Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS) treatment 1 / 2 withdrawn NCT01044576
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis No drug interventions Not Available Not Available completed NCT00869726
A Study for Patients With Secondary Progressive Multiple Sclerosis treatment 2 / 3 completed NCT00870155
A Study for Patients With Multiple Sclerosis treatment 2 / 3 terminated NCT00559702
Safety Study of Natalizumab to Treat Multiple Sclerosis (MS) treatment 1 completed NCT03282760
Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients No drug interventions treatment 1 completed NCT01466114
Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition treatment 2 unknown_status NCT04792567
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) treatment 4 completed NCT05327322
Functional Outcomes From Diets in Multiple Sclerosis No drug interventions other Not Available recruiting NCT04411641
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) treatment 3 active_not_recruiting NCT03471338
Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme No drug interventions other Not Available active_not_recruiting NCT02296346
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis No drug interventions treatment Not Available terminated NCT02330965
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis No drug interventions Not Available Not Available completed NCT02208050
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS treatment 4 completed NCT01917019
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis treatment 3 completed NCT01077466
Natalizumab Treatment of Progressive Multiple Sclerosis treatment 2 completed NCT00813969
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS No drug interventions treatment 1 completed NCT00257855
A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis treatment 2 completed NCT05893225
Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration treatment 2 recruiting NCT03935529
Behavioural Activation for Low Mood in Multiple Sclerosis No drug interventions supportive_care Not Available completed NCT06599307
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis supportive_care 2 recruiting NCT01235455
Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors Not Available Not Available completed NCT03696485
Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS No drug interventions treatment 1 / 2 withdrawn NCT03387670
Multiple Sclerosis-Simvastatin Trial 2 treatment 3 unknown_status NCT04593927
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients Not Available Not Available completed NCT01233245
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program Not Available Not Available completed NCT01804647
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease No drug interventions Not Available Not Available completed NCT01848327
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis No drug interventions treatment Not Available completed